Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists

Robert J Wilson1, Edgars Jecs1, Eric J Miller1

  • 1Department of Chemistry, Emory University, 1515 Dickey Drive NE, Atlanta, Georgia 30322, United States.

Insights

New CXCR4 antagonists derived from 2-(aminomethyl)pyridine offer improved stability and accessibility compared to older tetrahydroquinoline-based compounds. These novel agents show promise for cancer therapy by targeting cancer cell proliferation and spread.

Area of Science:

  • Oncology
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • Chemokine receptor CXCR4 is overexpressed on various cancer cells.
  • CXCR4 overexpression correlates with cancer metastasis, angiogenesis, and tumor growth.
  • CXCR4 antagonists can potentially reduce cancer cell viability by disrupting pro-survival signaling and chemotaxis.

Purpose of the Study:

  • To develop novel CXCR4 antagonists with improved properties.
  • To explore 2-(aminomethyl)pyridine analogs as alternatives to rigid tetrahydroquinoline structures.
  • To evaluate the medicinal chemistry strategy and biological activity of these new compounds.

Main Methods:

  • Synthesis of 2-(aminomethyl)pyridine analogs.
  • Medicinal chemistry optimization.
  • Evaluation of biological properties, including liver microsomal stability and anti-cancer activity.

Main Results:

  • Developed novel CXCR4 antagonists based on 2-(aminomethyl)pyridine.
  • Achieved improved liver microsomal stability compared to previous analogs.
  • Demonstrated potential for diminishing cancer cell viability through targeted inhibition.

Conclusions:

  • 2-(aminomethyl)pyridine analogs represent a promising scaffold for CXCR4 antagonist development.
  • These novel compounds offer advantages in accessibility and stability for potential cancer therapeutics.
  • Further investigation is warranted to explore their full therapeutic potential in cancer treatment.

Related Concept Videos

Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
993
Dehydration Synthesis01:15

Dehydration Synthesis

Overview
Dehydration synthesis (also called a condensation reaction) is the chemical process in which two molecules covalently link together to form a new molecule, along with the release of a water molecule. Many physiologically important compounds form by dehydration synthesis reactions, such as complex carbohydrates, proteins, DNA, and RNA.
Synthesis of carbohydrates
Sugar molecules are covalently linked together by dehydration synthesis. During the reaction, the hydroxyl (-OH) group from...
150.6K
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
13.4K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K
Synthesis and Decomposition Reactions02:17

Synthesis and Decomposition Reactions

Synthesis and decomposition are two types of redox reactions. Synthesis means to make something, whereas decomposition means to break something. The reactions are accompanied by chemical and energy changes. 
38.4K
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.8K